Literature DB >> 36266353

Base editor scanning charts the DNMT3A activity landscape.

Nicholas Z Lue1,2, Emma M Garcia1,2, Kevin C Ngan1,2, Ceejay Lee1,2, John G Doench2, Brian B Liau3,4.   

Abstract

DNA methylation is critical for regulating gene expression, necessitating its accurate placement by enzymes such as the DNA methyltransferase DNMT3A. Dysregulation of this process is known to cause aberrant development and oncogenesis, yet how DNMT3A is regulated holistically by its three domains remains challenging to study. Here, we integrate base editing with a DNA methylation reporter to perform in situ mutational scanning of DNMT3A in cells. We identify mutations throughout the protein that perturb function, including ones at an interdomain interface that block allosteric activation. Unexpectedly, we also find mutations in the PWWP domain, a histone reader, that modulate enzyme activity despite preserving histone recognition and protein stability. These effects arise from altered PWWP domain DNA affinity, which we show is a noncanonical function required for full activity in cells. Our findings highlight mechanisms of interdomain crosstalk and demonstrate a generalizable strategy to probe sequence-activity relationships of nonessential chromatin regulators.
© 2022. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Year:  2022        PMID: 36266353     DOI: 10.1038/s41589-022-01167-4

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   16.174


  56 in total

1.  Mutations in DNA methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation.

Authors:  Celeste Holz-Schietinger; Doug M Matje; Norbert O Reich
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

Review 2.  Function and information content of DNA methylation.

Authors:  Dirk Schübeler
Journal:  Nature       Date:  2015-01-15       Impact factor: 49.962

Review 3.  DNMT3A in Leukemia.

Authors:  Lorenzo Brunetti; Michael C Gundry; Margaret A Goodell
Journal:  Cold Spring Harb Perspect Med       Date:  2017-02-01       Impact factor: 6.915

4.  DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Authors:  M Okano; D W Bell; D A Haber; E Li
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

5.  Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.

Authors:  Allison Mayle; Liubin Yang; Benjamin Rodriguez; Ting Zhou; Edmund Chang; Choladda V Curry; Grant A Challen; Wei Li; David Wheeler; Vivienne I Rebel; Margaret A Goodell
Journal:  Blood       Date:  2015-01-22       Impact factor: 22.113

Review 6.  DNA methylation: a historical perspective.

Authors:  Alexandra L Mattei; Nina Bailly; Alexander Meissner
Journal:  Trends Genet       Date:  2022-04-30       Impact factor: 11.821

7.  DNMT3L stimulates the DNA methylation activity of Dnmt3a and Dnmt3b through a direct interaction.

Authors:  Isao Suetake; Fuminori Shinozaki; Junichi Miyagawa; Hideyuki Takeshima; Shoji Tajima
Journal:  J Biol Chem       Date:  2004-04-21       Impact factor: 5.157

8.  Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo.

Authors:  Mira Jeong; Hyun Jung Park; Hamza Celik; Elizabeth L Ostrander; Jaime M Reyes; Anna Guzman; Benjamin Rodriguez; Yong Lei; Yeojin Lee; Lei Ding; Olga A Guryanova; Wei Li; Margaret A Goodell; Grant A Challen
Journal:  Cell Rep       Date:  2018-04-03       Impact factor: 9.423

9.  Gain-of-function DNMT3A mutations cause microcephalic dwarfism and hypermethylation of Polycomb-regulated regions.

Authors:  Patricia Heyn; Clare V Logan; Adeline Fluteau; Rachel C Challis; Tatsiana Auchynnikava; Carol-Anne Martin; Joseph A Marsh; Francesca Taglini; Fiona Kilanowski; David A Parry; Valerie Cormier-Daire; Chin-To Fong; Kate Gibson; Vivian Hwa; Lourdes Ibáñez; Stephen P Robertson; Giorgia Sebastiani; Juri Rappsilber; Robin C Allshire; Martin A M Reijns; Andrew Dauber; Duncan Sproul; Andrew P Jackson
Journal:  Nat Genet       Date:  2018-11-26       Impact factor: 38.330

10.  The Tatton-Brown-Rahman Syndrome: A clinical study of 55 individuals with de novo constitutive DNMT3A variants.

Authors:  Katrina Tatton-Brown; Anna Zachariou; Chey Loveday; Anthony Renwick; Shazia Mahamdallie; Lise Aksglaede; Diana Baralle; Daniela Barge-Schaapveld; Moira Blyth; Mieke Bouma; Jeroen Breckpot; Beau Crabb; Tabib Dabir; Valerie Cormier-Daire; Christine Fauth; Richard Fisher; Blanca Gener; David Goudie; Tessa Homfray; Matthew Hunter; Agnete Jorgensen; Sarina G Kant; Cathy Kirally-Borri; David Koolen; Ajith Kumar; Anatalia Labilloy; Melissa Lees; Carlo Marcelis; Catherine Mercer; Cyril Mignot; Kathryn Miller; Katherine Neas; Ruth Newbury-Ecob; Daniela T Pilz; Renata Posmyk; Carlos Prada; Keri Ramsey; Linda M Randolph; Angelo Selicorni; Deborah Shears; Mohnish Suri; I Karen Temple; Peter Turnpenny; Lionel Val Maldergem; Vinod Varghese; Hermine E Veenstra-Knol; Naomi Yachelevich; Laura Yates; Nazneen Rahman
Journal:  Wellcome Open Res       Date:  2018-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.